Podcasts about regulatory

Bitcoin is increasingly being shaped not just by markets, but by policy, as regulators around the world split into six distinct regulatory paths that could dramatically alter adoption, capital flows, and innovation. From Washington's stalled legislation and shifting SEC–CFTC dynamics to global divergence between enforcement-heavy regimes and innovation-friendly frameworks, today's stories highlight a growing reality: regulatory clarity is becoming a competitive advantage.

New @greenpillnet pod out today!

Dr. Kelly Cohen is a Professor of Aerospace Engineering at the University of Cincinnati and a leading authority in explainable, certifiable AI systems. With more than 31 years of experience in artificial intelligence, his research focuses on fuzzy logic, safety-critical systems, and responsible AI deployment in aerospace and autonomous environments. His lab's work has received international recognition, with students earning top global research awards and building real-world AI products used in industry.In this episode 190 of the Disruption Now Podcast,

In this enlightening episode of 90 Miles from Needles, host Chris Clarke explores the intricate world of bees with Mary O' Brien from Project 1100. The conversation delves into the potentially deleterious effects of honeybee apiaries on public lands, a topic that's both counterintuitive and crucial for the public to understand. Honeybees, although often seen as critical to agriculture and ecosystems, can pose significant threats to native solitary bees that have co-evolved with local flowering plants. Mary O' Brien sheds light on how these industrious honeybees outcompete their native cousins, impacting pollination dynamics that are vital for the desert's diverse flora. Listeners will gain valuable insights into the importance of preserving native bee species, the complexities of their ecological roles, and the nuanced implications of honeybee proliferation. O'Brien also shares practical strategies for those interested in conservation, emphasizing the importance of habitat protection and mindful consumerism when it comes to honey and pollinator support. Key Takeaways: Honeybees, although widely supported and utilized in agriculture, can have adverse effects on native bee populations, outcompeting them for resources and spreading diseases. The high reproductive rate of honeybees poses a threat to native plants relying on solitary native bees for pollination, potentially destabilizing ecosystems. Public lands serve as critical refuges for native bee species, which are often overlooked in conventional conservation discussions. Consumers can contribute to bee conservation efforts by choosing their honey responsibly and fostering habitats for native pollinators. Regulatory frameworks around public land usage play a significant role in the sustainability of native bee populations, calling for increased transparency and stakeholder engagement. Notable Quotes: "Trying to save bees by saving the honeybee is like trying to save birds by saving the chicken." "Native bees evolved in tandem with flowers, and honeybees are not very good pollinators of many species of plants." "Once you know native solitary bees are in your world, you really can delight in seeing such diversity." "Public lands are the wildflower repositories for the Western U.S.; especially in the desert." "It's often quite attractive to think that you're buying wildflower honey; however, you're almost certainly buying honey that was produced on public land." Resources: Project 1100 Website Xerces Society for Invertebrate Conservation The Forgotten Pollinators by Stephen Buchmann and Gary Nabhan Common Bees of Western North America laminated guide Center for Biological Diversity resources on pollinators: Bees Pollinators Pollinators in Peril report Discover the intricate dynamics between honeybees and native pollinators and why preserving the biodiversity of our desert ecosystems is more crucial than ever. Listen to the full episode to deepen your understanding of this vital subject and stay tuned to 90 Miles from Needles for more insightful discussions on desert conservation. Podcast episode artwork: Mojave poppy bee (Perdita meconis). Photo courtesy Zach Portman / University of Minnesota Department of Entomology via the Nevada Independent.Become a desert defender!: https://90milesfromneedles.com/donateSee omnystudio.com/listener for privacy information.

Scrip senior editor Jessica Merrill, Scrip US managing editor Mandy Jackson and In Vivo senior reporter David Wild discuss trends and topics from interviews and presentations at the J.P. Morgan Healthcare Conference and Biotech Showcase.

In this episode of Talk Fantasy To Me, Kyle dives into the latest developments in the entertainment industry, focusing on Netflix's acquisition of Warner Bros. and the implications for Hollywood. The discussion covers the potential impact on consumer choice, the future of theatrical releases, and the role of AI in content creation. Kyle also explores Paramount's counter-offer and the broader industry dynamics at play.   Takeaways Netflix's acquisition of Warner Bros. could reshape Hollywood. Paramount's counter-offer adds complexity to the deal. AI's role in content creation is expanding. The future of theatrical releases is uncertain. Consumer choice may be impacted by media consolidation. The entertainment industry is at a crossroads. Regulatory scrutiny is expected for the Netflix deal. Paramount's all-cash offer is seen as superior by some. The merger could lead to significant industry changes. Hollywood's traditional model is being challenged.   Sound bites "Netflix's acquisition could reshape Hollywood." "Paramount's offer adds complexity." "AI is changing content creation." "The future of theaters is uncertain." "Consumer choice is at risk." "Hollywood is at a crossroads." "Regulatory scrutiny is expected." "Paramount's offer is seen as superior." "The merger could change the industry." "Hollywood's model is challenged."   Chapters 00:00:00 Introduction to the Episode 00:03:00 Netflix's Acquisition of Warner Bros. 00:09:00 Paramount's Counter-Offer 00:15:00 AI's Role in Content Creation 00:21:00 Impact on Theatrical Releases 00:27:00 Consumer Choice and Media Consolidation 00:33:00 Regulatory Scrutiny and Industry Changes 00:39:00 Conclusion and Future Outlook    

Escalating distrust in identity systems and misuse of AI are forcing a shift in security accountability for small and midsize businesses. Recent analysis highlights that the prevalence of deepfake-driven business email compromise and non-human digital identities is eroding confidence in traditional protective solutions. According to Techyle and supporting reports referenced by Dave Sobel, the ratio of non-human to human identities in organizations is now 144:1, further complicating authority and responsibility for managed service providers (MSPs). As trust in exclusive third-party control disintegrates, co-managed security models are becoming standard, repositioning decision-making and liability.The rise of AI-generated data—described as “AI slop”—has prompted increased adoption of zero trust models, with 84% of CIOs reportedly increasing funding for generative AI initiatives. However, as rogue AI agents are recognized as a significant insider threat, current security services are often ill-equipped to manage these new vulnerabilities. Regulatory bodies, including CISA, have issued guidance noting that the integration of AI into critical infrastructure introduces greater risk of outages and security breaches, particularly when governance remains ambiguous. High-profile vulnerabilities in open-source AI platforms used within cloud environments further highlight the persistence of operational risks.Adjacent technology updates include new releases from vendors such as 1Password, WatchGuard, JumpCloud, and ControlUp. These offerings focus on enhancing phishing prevention, expanding managed detection and response, and automating endpoint management for MSPs. However, Dave Sobel emphasizes that these tools introduce additional layers of automation and integration without adequately clarifying who ultimately holds authority and accountability when failures or breaches occur. There is a consistent warning that stacking solutions or outsourcing core functions without redefining operational control creates gaps between action and oversight.For MSPs and IT leaders, the key takeaway is that security risk is no longer defined by missing technology but by unclear governance, undefined authority, and misaligned incentives. Without explicit contractual and operational delineation of responsibility when deploying AI and automation, service providers are increasingly exposed to liability by default. The advice is to move beyond tool-centric strategies and focus on process clarity: define who authorizes, audits, and terminates non-human identities; establish which parties approve automation actions; and ensure clients understand shared responsibilities to mitigate silent risk accumulation. Four things to know today00:00 TechAisle Warns SMB Security Will Shift in 2026 as Identity Attacks and AI Agents Redefine Risk05:44 AI Moves Deeper Into Critical Infrastructure as Open-Source and Human Weaknesses Expand the Attack Surface09:35 MSP Security Platforms Automate Phishing Prevention and MDR—Outpacing Governance and Control Models12:12 AI-Powered MSP Tools Promise Control and Efficiency, But Shift Responsibility by Default This is the Business of Tech.    Supported by:  https://scalepad.com/dave/

In this episode of Medsider Radio, we sat down with Greg Walters, co-founder & CEO of Excision Medical. Excision is developing a leaflet modification system to enable lifetime management of aortic stenosis.Greg has almost 40 years of experience in cardiovascular devices, holding leadership roles at Kensey Nash Corporation where he led the development of Angio-Seal and several endovascular programs. He later co-founded Essential Medical, which was acquired by Teleflex in 2018, and is an inventor on more than 75 U.S. and European patents.In this interview, Greg discusses why early-stage teams should build to learn rather than to impress, using functional prototypes to generate real feedback and fundraising momentum. He outlines how disciplined safety work — not perfection — defines first-in-human readiness, and what makes a pre-revenue company attractive to strategic acquirers. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Greg Walters.

In this episode of The Product Experience, host Randy Silver talks with Cristina Bustos, Product Manager and team lead at Swiss AviationSoftware, about her experience launching a native mobile application in one of the most regulated and high‑stakes industries in the world: commercial aviation.Cristina recounts how she moved from business analysis into product leadership and then navigated a gruelling product development process during the pandemic. Her team faced the dual challenge of winning over both paying customers and aviation regulators to replace paper‑based cockpit workflows with a real‑time digital solution.Chapters0:00 | Introduction and personal background 2:34 | Problem framing: launching a mobile app in aviation 4:00 | Winning founding customers before building code 6:10 | Consensus across customers and regulators 9:00 | Involving actual pilots in design 10:00 | Redesigning workflow not just digitising it 14:15 | Scope control and prioritisation 17:16 | Regulatory engagement and approval strategy 19:49 | A hackathon that wasn't a silver bullet 21:06 | Reflections: what she would do differently 25:22 | Balancing iteration with regulatory discipline 28:21 | Triple validate in the real world 29:53 | Signals of success and business impactOur HostsLily Smith enjoys working as a consultant product manager with early-stage and growing startups and as a mentor to other product managers. She's currently Chief Product Officer at BBC Maestro, and has spent 13 years in the tech industry working with startups in the SaaS and mobile space. She's worked on a diverse range of products – leading the product teams through discovery, prototyping, testing and delivery. Lily also founded ProductTank Bristol and runs ProductCamp in Bristol and Bath. Randy Silver is a Leadership & Product Coach and Consultant. He gets teams unstuck, helping you to supercharge your results. Randy's held interim CPO and Leadership roles at scale-ups and SMEs, advised start-ups, and been Head of Product at HSBC and Sainsbury's. He participated in Silicon Valley Product Group's Coaching the Coaches forum, and speaks frequently at conferences and events. You can join one of communities he runs for CPOs (CPO Circles), Product Managers (Product In the {A}ether) and Product Coaches. He's the author of What Do We Do Now? A Product Manager's Guide to Strategy in the Time of COVID-19. A recovering music journalist and editor, Randy also launched Amazon's music stores in the US & UK.

What if the failure rate in clinical trials isn't about picking the wrong drug candidates—but about testing them in the wrong models?When you move cells from a 2D culture plate into a bioreactor, you're not simply scaling volume. You're fundamentally changing the biological context. Cell density shifts. Mass transfer dynamics evolve. Mechanical cues emerge. The cells sense these changes and respond—often in ways that derail strategies built on oversimplified assumptions.Most preclinical research still relies on flat plastic surfaces and animal models that miss critical aspects of human biology. The result? Therapeutics fail late in development because the models couldn't predict how human tissues would actually respond.In this episode, David Brühlmann speaks with Catarina Brito, Principal Investigator at ITQB NOVA and Head of the Advanced Cell Models Laboratory at iBET and ITQB NOVA in Portugal. Catarina's career-defining insight came early: studying glycan-protein interactions in murine versus human cells revealed that species differences weren't just nuances—they were fundamental gaps that could mislead entire research programs.Catarina and her team have developed neural, liver, and tumor models that capture the multicellular complexity and microenvironmental cues that 2D cultures cannot replicate. Her work creates preclinical models sophisticated enough to predict human responses while remaining scalable for drug development workflows.Highlights of the episode:Limitations of traditional 2D cell cultures and animal models in capturing realistic tissue behavior and therapeutic responses (06:27)Catarina Brito's personal scientific journey: from discovering model limitations to pioneering 3D culture systems in neural and liver tissues (04:19)How advanced 3D models recreate cell-to-cell interactions, tissue-specific microenvironments, diffusion gradients, and multicellular complexity (10:35)Regulatory movements toward reducing animal models, and the challenge of validating advanced alternatives for systemic biology studies (09:10)Key differences in designing bioreactors for various cell types, with practical examples from liver and neural models (15:16)The impact of scalable, robust 3D models on accelerating drug development and improving selection of candidate therapies (17:22)Key Takeaway:Bioprocess development starts when you choose the model that validates your therapeutic approach. If that model can't capture the biology that matters, every downstream optimization is built on a flawed foundation.In Part 2, Catarina reveals how 3D tumor microenvironments expose drug resistance mechanisms invisible in 2D cultures, and her vision for AI-powered digital twins enabling personalized medicine.Subscribe & Review:If this conversation changed how you think about preclinical model selection, leave a review on Apple Podcasts. Your reviews help other biotech scientists discover these insights.For more CMC development insights, visit smartbiotechscientist.com.Connect with Catarina Brito:LinkedIn: www.linkedin.com/in/catarina-brito-ibetAdvanced Cell Models Lab – iBET: www.ibet.pt/laboratories/advanced-cell-models-labNext step:Need fast CMC guidance? → Get rapid CMC decision support hereSupport the show

Sarah Halko, Head of Regulatory and Industry Relations at TNS, joined Doug Green, Publisher of Technology Reseller News, for a Cloud Communications Alliance (CCA) podcast focused on the FCC's Do Not Originate (DNO) mandate and its role in combating robocalls and caller ID spoofing. Halko explained that DNO (Do Not Originate) identifies phone numbers that should never be used for outbound calling—such as invalid, unallocated, or inbound-only numbers like government agencies. Blocking calls that spoof these numbers allows service providers to stop obvious fraud earlier in the call path, before it reaches consumers. While DNO began as an optional tool in 2017, regulatory expectations have steadily increased. As of December 15, 2025, every service provider in the call flow must maintain a “reasonable DNO list,” making accurate, up-to-date data essential for compliance. “Without reliable, authoritative numbering data, service providers can't confidently determine which calls should be blocked,” Halko said. “DNO compliance ultimately depends on knowing how numbers are assigned, used, and routed in real time.” TNS supports providers by delivering trusted, continuously updated numbering and routing intelligence across the U.S., Canada, and the Caribbean. This enables earlier, more accurate call blocking and reduces the risk of false positives or missed fraudulent traffic. Looking ahead, Halko emphasized that DNO is only one part of a broader trust framework that also includes analytics, traceback, authentication (STIR/SHAKEN), and Know Your Customer practices—all working together to protect network integrity. Learn more: https://tnsi.com/

This episode is an interview with Aruna Dhontabhaktuni, Founder and CEO of RegKey, a regulatory intelligence platform that uses AI. The discussion touches on how companies can leverage large language model AI tools to accelerate regulatory strategy work.Links discussed in the show:You can contact Aruna by email: arunad@regkey.aiVisit the RegKey website Connect with Aruna on LinkedIn You can connect with Nathan on LinkedIn and send me a message Send Nathan a message Sign up for Nathan's newsletter Copyright Teuscher Solutions LLC

Join us for an exclusive deep dive into the science and new research behind P84 with two of LifeVantage's top research leaders, Lisa Barnes, VP of R&D and Regulatory, and Christina Beer, Director of Research. In this episode, they break down our newest P84 clinical studies in a way that's easy to understand and powerful to share. You'll learn what the research proves, why it matters for your health and your business, and how to confidently talk about the science behind P84 combined with Protandim.  If you've ever wanted to feel more confident explaining why P84 works — this episode is your go-to. Science made simple. Confidence made easy. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease

In this episode of The Future Conceived, host Cam Schmidt sits down with Dr. Jim Ferrell, Professor of Chemical and Systems Biology at Stanford University. Known for his pioneering work in the logic of cell signaling, Dr. Ferrell discusses the "mechanism" of life through the lens of physics, chemistry, and mathematics.Dr. Ferrell shares his journey from a triple major at Williams College to becoming a leading voice in Systems Biology. The conversation dives deep into:Biological Circuits: How evolution uses motifs like negative feedback and relaxation oscillators to create "all-or-none" switches and rhythmic pulses in cells.The "Blender" Experiment: A fascinating look at how frog egg extracts can self-organize from "homogenized garbage" back into complex, cell-like structures.Quantitative Reasoning: Why thinking like a physicist—using ordinary differential equations and reaction-diffusion models—is essential for moving biology beyond "stamp collecting" and toward a unifying theory of how life builds and repairs itself.Whether you are a trainee or an established researcher, this episode offers a profound perspective on how the integration of physical forces and biochemical activities brings about the events of life.

NHTSA extended Tesla's deadline to respond to an FSD investigation covering 8,313 potential traffic violations. The new February 23 deadline arrives just after Musk announced FSD will become subscription-only on February 14, the same day California's DMV gave Tesla to fix misleading marketing or face a sales ban. We break down what federal regulators are actually investigating, why Tesla is juggling three major probes simultaneously, and how the subscription pivot may be a legal hedge as regulators close in.

To help support the show:CashApp- ⁠https://cash.app/$drchrisloomdphd⁠Venmo- ⁠https://account.venmo.com/u/Chris-Loo-4⁠Buy Me a Coffee- ⁠https://www.buymeacoffee.com/chrisJx⁠Subscribe to our email list: ⁠https://financial-freedom-podcast-with-dr-loo.kit.com/⁠Click here to join PodMatch (the "AirBNB" of Podcasting): ⁠https://www.joinpodmatch.com/drchrisloomdphd⁠Click here to purchase my books on Amazon: ⁠https://amzn.to/2PaQn4p⁠For audiobooks, visit: ⁠https://www.audible.com/author/Christopher-H-Loo-MD-PhD/B07WFKBG1F⁠Disclaimer: Not advice. Educational purposes only. Not an endorsement for or against. Results not vetted. Views of the guests do not represent those of the host or show.  

In this episode, Adam Torres interviews Philip Recht, Partner at Mayer Brown LLP, about takeaways from the Milken Institute Middle East & Africa Summit in Abu Dhabi, the Gulf's rapid push into AI and data centers, and the legal and regulatory issues shaping global investment—from trade and national security to energy, critical minerals, and AI governance. Big thank you to ⁠⁠⁠⁠⁠⁠⁠⁠Milken Institute⁠⁠⁠⁠⁠⁠⁠⁠! About Philip Recht Co-leader of the firm's Public Policy, Regulatory & Government Affairs practice and former managing partner of the firm's Los Angeles office (2009-21), Phil Recht represents clients in legislative, regulatory, enforcement and litigation matters before and involving federal, state and local governments.Co-leader of the firm's Public Policy, Regulatory & Government Affairs practice and former managing partner of the firm's Los Angeles office (2009-21), Phil Recht represents clients in legislative, regulatory, enforcement and litigation matters before and involving federal, state and local governments. About Mayer Brown LLP Mayer Brown is a leading international law firm, positioned to represent the world's major corporations, funds and financial institutions in their most important and complex transactions and disputes. Follow Adam on Instagram at ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/askadamtorres/⁠⁠⁠⁠⁠⁠⁠⁠⁠ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://missionmatters.lpages.co/podcastguest/⁠⁠⁠⁠⁠⁠⁠⁠⁠ Visit our website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://missionmatters.com/ Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of the Milk Road Show, Coinbase's Head of Institutional Research David Duong breaks down the hidden "backdoor stimulus" that could inject $140 billion into the market, and why the stalling of the Clarity Act might not matter as much as investors fear.~~~~~

i'm wall-e, welcoming you to today's tech briefing for friday, january 16th. dive into today's top tech stories: microsoft's $10 billion ai investment: microsoft plans to invest in openai to enhance azure cloud services with advanced ai capabilities, focusing on natural language processing and machine learning. meta under eu scrutiny: eu regulators examine meta's user data handling and targeted advertising practices, with potential fines looming if they fail to comply with data protection rules. netflix subscriber surge: netflix reports a gain of 4 million new subscribers, attributing growth to successful investments in original content, surpassing wall street expectations. stay tuned for tomorrow's tech updates!

Our Global Head of Fixed Income Research Andrew Sheets looks at the implications of the U.S. government's efforts to ease regulations, from bank balance sheets to asset valuations.Read more insights from Morgan Stanley.----- Transcript -----Andrew Sheets: Welcome to Thoughts on the Market. I'm Andrew Sheets, Global Head of Fixed Income Research at Morgan Stanley. Today, a core theme of easing policy, and the latest iteration in the U.S. mortgage market. It's Thursday, January 15th at 2pm in London. Central to our thinking for the year ahead is that we're seeing an unusual combination of easing monetary policy, fiscal policy, and regulatory policy – all at the same time. This isn't normal, and usually this type of support is only deployed under much more dire economic conditions. All this is also happening alongside another large supportive force – over $3 trillion of AI- and datacenter-related spending that Morgan Stanley expects all to happen through the end of 2028. This broad-based easing is a global theme. Equities in Japan have been rallying on hopes of even a larger fiscal leasing in that country. In Europe, we think that Germany will continue to spend more while the European Central Bank and Bank of England cut rates more than the market expects.But like many things these days, it's the United States that's at the heart of the story. We think that the U.S. Federal Reserve will continue to lower interest rates this year, even as core inflation persists above its target. The U.S. government will spend about $1.9 trillion more than it takes in, even after adjusting for tariffs as tax cuts from the One Big Beautiful Bill Act kick in. But my focus today is on the third leg of this proverbial three-legged stimulative stool. While easing monetary and fiscal policy probably get the most focus, easing regulatory policy is another big lever that's being pulled in the same direction. Regulatory policy is opaque, and let's face it can be a little boring. But it's extremely important for how financial markets function. Regulation drives the incentives for the buyers of many assets, especially in the all-important banking and insurance sectors. It can set almost by definition what price an asset needs to trade at to be attractive, or how much of an asset a particular actor in the market can or cannot hold. Regulatory policy tightened dramatically in the wake of the Global Financial Crisis, but now it's starting to ease. Our U.S. bank equity analysts expect that finalization of key capital rules later this year – an important regulatory step – could free up about [$]5.8 trillion – with a T – of balance sheet capacity across the Global Systematically Important Banks. In mid-December, the office of the comptroller of the currency and the FDIC withdrew lending guidelines from 2013 that had discouraged banks from making loans to more highly indebted companies. And just last week, the U.S. administration announced that the U.S. mortgage agencies, Fannie Mae and Freddie Mac would buy [$]200 billion of mortgages to hold on their own balance sheet; a significant move that quickly tightens spreads in this key market. For investors, we see several implications. This simultaneous easing across monetary, fiscal, and now regulatory policy supports a market that runs hot and where valuations may overshoot. And in the specific case of these agency mortgages, my colleague Jay Bacow and our mortgage strategy team think that this shift is now very quickly in the price. Having previously been positive on agency mortgage spreads, they've now turned to neutral. Thank you as always for your time. If you find Thoughts on the Market useful, let us know by leaving a review wherever you listen. And also tell a friend or colleague about us today.

In this episode of FYI – For Your Innovation, ARK's CEO Cathie Wood hosts a wide-ranging conversation with Marco Santori, CEO of Solmate, and Dr. Arthur Laffer, renowned economist and longtime ARK advisor. Together, they explore the evolving crypto landscape, regulatory shifts, and why Solana is emerging as a powerful foundation for next-generation financial infrastructure. Santori, previously Chief Legal Officer at Kraken and General Partner at Pantera, shares why he's now focused on building Solmate atop the Solana blockchain—and why the Middle East is a critical part of that strategy. He explains Solana's technical advantages, from base-layer speed to support for smart contracts, and its potential to become the platform of choice for high-frequency trading, AI-driven transactions, and decentralized financial services. Dr. Laffer brings historical context to the conversation, contrasting private and government-controlled currencies and making the case for innovation in monetary systems. He also reflects on why he joined the board of Solmate and what excites him about its approach to financial infrastructure and economic growth.Key Points From This Episode:●      [0:00] Meet the guests: Marco Santori's legal background and early Solana investment●      [4:45] Regulatory whiplash: How the U.S. landscape shifted under a new administration●      [7:16] Dr. Laffer's crypto “aha” moment and the history of private money●      [13:30] Why Marco chose Solana: performance, smart contracts, and AI readiness●      [18:05] Ethereum vs. Solana: decentralization, speed, and Wall Street applications●      [23:27] Solmate's board and Middle East connections●      [30:14] Why the United Arab Emirates (UAE) is betting on Solana●      [37:09] The evolution of Solmate from digital asset treasury to infrastructure company●      [42:38] Revenue strategy: building cash flow, not just holding tokens●      [46:23] The Middle East as a geographic and latency hub for blockchain innovation●      [51:06] High-frequency transacting: the next frontier in trading●      [52:31] Solana and on-chain prediction markets

We speak with a rose grower about the market and supply for Valentine's Day.Farm Bureau president talks about the cost of regulations sinking farmers.The pear industry seeks relief from a flood of imports.A webinar series for those transitioning to organic farming.

Medboard: https://www.medboard.com/EuropeEMD Mag Issue 3 - For QA RA people: https://easymedicaldevice.com/emd-mag/EU to simplify MDR and IVDR - Proposal ongoing: https://health.ec.europa.eu/document/download/25e7ea7c-cab3-40cf-86d9-d11f5e7744d8_en?filename=md_com_2025-1023_act_en.pdf  -  https://ec.europa.eu/commission/presscorner/api/files/document/print/en/qanda_25_3078/QANDA_25_3078_EN.pdf  -  https://ec.europa.eu/commission/presscorner/api/files/attachment/882087/FACTSHEET%20medical%20devices%20final%20(1).pdfTeam NB Position Paper on Annex VII - Not agreeing all EU Proposal: https://www.team-nb.org/wp-content/uploads/2025/12/Team-NB-PositionPaper-Annex-VII-V1-20251216.pdfMDCG 2025-9 Learn Breakthrough Devices BtX - Guidance for innovative products: https://health.ec.europa.eu/document/download/edca94c7-62ab-4dd5-8539-2b347bd14809_en?filename=mdcg_2025-9.pdfInfographic: https://www.linkedin.com/posts/melazzouzi_medtech-mdr-ivdr-activity-7414590943179202560-jbxH?utm_source=share&utm_medium=member_desktop&rcm=ACoAAABZ07ABDocaBMTLJo8bsl8V3bgNSBIiZuIMDCG 2025-10 on PMS - Learn how to do it with this guidance: https://health.ec.europa.eu/document/download/a9ad86b7-1b8e-4bae-beb4-48b2b3ed2f05_en?filename=mdcg_2025-10_en.pdfNotified Body Malta Conformity Assessment - 52nd Notified Body for MDR: https://webgate.ec.europa.eu/single-market-compliance-space/notified-bodies/notifications?organizationRefeCd=SIMS_INPUT_282916&filter=notificationStatusId:1  ServicesEasyIFU - Manage your eIFU and Labels: https://easyifu.com SwitzerlandSwissdamed registration deadline - July 1st 2026: https://www.swissmedic.ch/swissmedic/en/home/medical-devices/medizinprodukte-datenbank/swissdamed-informationen/frist-produktregistrierung-in-swissdamed.html - https://swissdamed-webinar.ch/#E402A0UKMHRA Price changing -: More cost for manufacturers: https://www.gov.uk/guidance/register-medical-devices-to-place-on-the-market#fees RoWFDA: How to use Real World Evidence - Guidance Document offered: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-real-world-evidence-support-regulatory-decision-making-medical-devicesAustralia: Preparing for UDI and AusUDID - Checklist for preparation available: https://www.tga.gov.au/sites/default/files/2025-12/preparing-for-udi-in-australia-checklist_0.pdf PodcastPodcast Nostalgia - What was discussed lastly: Episode 367 - From Engineer to Clinical Evaluation Expert - Florian Tolkmitt: https://podcast.easymedicaldevice.com/367-2/Episode 368 - Simplifying EU MDR IVDR with Adam Isaacs Rae: https://podcast.easymedicaldevice.com/368-2/Episode 369 - Last Podcast of the Year: https://podcast.easymedicaldevice.com/369-2/Episode 370 - Verification & Validation with Aaron Joseph: https://podcast.easymedicaldevice.com/370-2/

Today my guest is Renuka Sane who is the managing director of Managing Director of Trustbridge. An institution that seeks to improve India's business environment by improving the rule of law. Renuka was a member of many expert committees including: the Task Force of Experts set up by the Employees Provident Fund Organisation; the research team of the Bankruptcy Legislative Reforms Commission; the Pension Advisory Committee of the Pension Fund Regulatory Development Authority; and the Working Group on personal insolvency at the Insolvency and Bankruptcy Board of India. She received a Ph.D. in Economics from the University of New South Wales.  We talked about the old, new, and unified pension scheme and related reforms over the last few decades in India, India's broader financial regulation framework, separation of powers in regulatory authorities, the way regulatory orders are written, and much more.  Recorded December 17th, 2025. Read a full transcript enhanced with helpful links. Learn more about The 1991 Fellowship. Connect with Ideas of India Follow us on X Follow Shruti on X Follow Renuka on X Click here for the latest Ideas of India episodes sent straight to your inbox. Timestamps (00:00:00) - The 1991 Fellowship (00:01:09) - Intro (00:02:49) - India's Pension System (00:35:42) - Private Sector Pension Schemes (01:06:28) - Regulatory Orders (01:24:03) - Improving Transparency at the Reserve Bank of India (01:34:57) - Outro  

Welcome to today’s RealAg Radio, brought to you by the Saskatchewan Crops Forum! On today’s show, hear host Lyndsey Smith moderating the national farm leadership panel in Saskatoon, Saskatchewan at the Saskatchewan Crops Forum. For the panel discussion, Smith is joined by: Rick White of Canadian Canola Growers Association; Jeff English of Pulse Canada; Scott... Read More

Join host David Turetsky and guest Paul Reiman from Novo Insights as they delve into the dynamic world of compensation strategies and pay transparency. Discover how regulatory changes in the US and Europe are shaping the landscape, the critical role of job documentation, and the impact of technology in fostering transparency. Tune in for insightful predictions for 2026 and learn how political climates may influence future pay transparency laws. Chapters Introduction and Guest Introduction Compensation Strategies and Pay Transparency Regulatory Changes in the US and Europe The Role of Technology in Transparency Predictions for 2026 Conclusion and Final Thoughts Quotes: "Job documentation is crucial for pay transparency." "Regulatory changes are reshaping the compensation landscape." "Expect a shift in compensation survey methodologies by 2026." "Technology plays a key role in enabling transparency." "Implementing pay transparency presents unique challenges." "2026 will bring significant changes to HR practices." "Adapting to regulatory changes is essential for success."

Welcome to today’s RealAg Radio, brought to you by the Saskatchewan Crops Forum! On today’s show, hear host Lyndsey Smith moderating the national farm leadership panel in Saskatoon, Saskatchewan at the Saskatchewan Crops Forum. For the panel discussion, Smith is joined by: Rick White of Canadian Canola Growers Association; Jeff English of Pulse Canada; Scott... Read More

The Transformation Ground Control podcast covers a number of topics important to digital and business transformation. This episode covers the following topics and interviews:   New Tech Laws of 2026, Q&A (Darian Chwialkowski, Third Stage Consulting) Legal Shifts and Regulatory Pressures in the ERP Space (Marcus Harris, Taft Law) Digital Transformation Mistakes that CFO's Often Make We also cover a number of other relevant topics related to digital and business transformation throughout the show.  

In this episode, host Jeremy Schrand welcomes Tim Schroeder, Founder & CEO of CTI, Jaqueline Aguiar, Managing Director of APAC/LATAM, and Dr. Ludwig Baumann, Global Regulatory Strategist, for an in-depth conversation about the Asia Pacific region's growing impact on clinical research. Together, they explore how population diversity, regulatory innovation, and advanced therapies are shaping the future of clinical trials. The discussion highlights real-world examples, regional strategies, and the evolving role of technology and local expertise in bringing new therapies to patients worldwide.01:33 Welcome to the guests and setting the stage for the discussion.01:50 Key drivers behind Asia Pacific's growth: globalization of research, population scale, rare disease focus, and the need for global market access.03:04 Panelists discuss the region's diversity, infrastructure maturation, and regulatory harmonization efforts (ASEAN guidelines, mutual recognition).05:10 Addressing past concerns about research qualityin Asia Pacific and how they've been resolved.06:15 CTI's strategic expansion into Asia Pacific:doubling of work, global footprint, and real-world examples from COVID-19 vaccine trials in Singapore and Vietnam.08:17 Operational hurdles: regulatory fragmentation, cultural and language diversity, and government investment in science and digital health.10:10 Managing regulatory variability: importance of local expertise, adapting to evolving guidelines, and leveraging relationships with regulators.12:10 Harmonization and efficiency: Singapore's reliance model, Australia's streamlined processes, and their influence as regional role models.14:26 Decentralized and virtual trials post-COVID: remote monitoring, reasons for choosing Australia (speed, tax credits) vs. China (population, cost).16:07 Executing complex, multi-country trials: pivotal registration studies, remote monitoring, and the importance of experienced investigators.18:05 Readiness for advanced therapies: academic medical centers' preparedness, regulatory interest in cell and gene therapy, and the need for in-depth preparation for combination products.20:27 Regulatory flexibility: pre-meetings with authorities, addressing language barriers, and successful integration of Asia Pacific into global trials.22:01 Talent acquisition and retention: strategies for building consistent, high-quality teams across diverse countries.23:53 Patient recruitment: cultural nuances and ensuring data quality and patient retention.26:09 Looking ahead: the impact of AI, harmonization, and infrastructure development on accelerating clinical trial execution in Asia Pacific.28:13 Recent success story: FDA approval of a rare disease drug with global patient participation, highlighting Asia Pacific's role.29:05 Closing thoughts: Asia Pacific's leadership in innovation, regulatory adaptation, and inclusion of rare patient populations.

Today's blockchain and crypto news Bitcoin is up slightly at $91,977  Ethereum is up slightly at $3,131 And Binance Coin is up slightly at $908 Former NY Mayor Eric Adams accused of rug pull. BitGo files amended registration BitMine buys more ETH Blockchain Regulatory Certainty act introduced ###Gemini Card Disclosure: The Gemini Credit Card is issued by WebBank. In order to qualify for the $200 crypto intro onus, you must spend $3,000 in your first 90 days. Terms Apply. Some exclusions apply to instant rewards in which rewards are deposited when the transaction posts. This content is not investment advice and trading crypto involves risk. For more details on rates, fees, and other cost information, see Rates & Fees. The Gemini Credit Card may not be used to make gambling-related purchases.  ### For 40% off your order, head to Udacity.com/DCR and use code DCR. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode 78: Outsourced Compliance with Fizza Khan, Silver Regulatory Associates Fizza Khan from Silver Regulatory Associates visits the Tokens of Wisdom Studio to enlighten us about all things compliance. From deciding when to engage an outsourced provider to the nuts and bolts of compliance policies and navigating SEC exams, Fizza shares the wisdom.  Key Points From This Episode: How does an outsourced compliance engagement work? Compliance policies – is it one size fits all, or are they custom to the adviser?What goes into compiling an effective set of policies?How are you involved in regulatory exams?When should a manager consider engaging outsourced compliance?How do you charge for your services? How should I choose the right outsourced compliance provider? What's the smartest thing a new fund manager can do?  Disclaimer: This show is for informational purposes only. Nothing presented here constitutes legal, investment or tax advice. The guests that join us share their considerable fund-related wisdom, but everything they share here is their personal opinion and for educational purposes only. On this show, they are speaking for themselves, and not for their employer or any affiliated entity. Tokens of Wisdom is produced by Dave Rothschild, partner at Cole-Frieman & Mallon LLP headquartered in San Francisco, California. For more information, visit https://colefrieman.com/ Links Mentioned in Today's Episode: Dave Rothschild - https://www.linkedin.com/in/davidcrothschild/Fizza Khan - https://www.linkedin.com/in/fizzakhan1/ Cole-Frieman & Mallon LLP - https://colefrieman.com/Silver - https://silverregulatoryassociates.com/    Music by Joe Ginsberg - https://www.instagram.com/thejoeginsbergFor any questions or comments, email: tow@colefrieman.com

In this episode of Medsider Radio, we sat down with Jaeson Bang, Founder & CEO of Future Cardia. Future Cardia is developing a subcutaneous heart-failure monitoring platform designed to capture both electrical and mechanical cardiac signals through a simple office-based procedure.Jaeson brings more than two decades of experience building implantable cardiac technologies across Medtronic, CVRx, EBR Systems, and Abiomed. Drawing on that background, he questioned industry assumptions around miniaturization and invasive workflows — and built a device that prioritizes performance, durability, and clinical practicality instead.In this interview, Jaeson shares how challenging a core constraint unlocked a faster development path, why deep domain expertise matters more than thrift in regulated markets, and how raising capital outside traditional VC can preserve leverage and buy time.If you'd rather read than listen, here's a link to the full interview with Jaeson Bang.

In this episode of Credit Union Conversations, host Mark Ritter sits down with Gord Baizley, Co-Founder and CEO of Judi.ai, to explore why small business lending remains one of the greatest untapped opportunities for credit unions—and how technology is finally making it scalable.Gord shares his unique career journey from law and investment banking to leading high-growth technology companies, including Judi.ai, a platform purpose-built to simplify and modernize small business lending. The conversation breaks down why small businesses are consistently underserved by traditional financial institutions despite representing a massive share of the economy—and why credit unions are uniquely positioned to close that gap.Mark and Gord dive into the cultural, regulatory, and operational barriers that have historically slowed small business lending at credit unions. They discuss how outdated underwriting expectations, CRE-centric credit culture, and manual processes have made small business lending feel complex and costly. Gord explains how predictive AI, real-time cash flow data, and automation are reshaping underwriting—allowing credit unions to treat small business lending more like consumer credit cards than commercial real estate.The episode also compares U.S. and Canadian banking systems, highlights the importance of executive buy-in, and reinforces why small business owners are “relationship unicorns” for credit unions—bringing deposits, loans, mortgages, and long-term loyalty.This episode is essential listening for credit union leaders, lenders, and executives looking to grow relationships, diversify loan portfolios, and compete effectively with fintech lenders.What You Will Learn in This Episode: ✅ Why small business lending should be treated as its own segment, not lumped into consumer or commercial lending.✅ How predictive AI and real-time cash flow data can dramatically reduce underwriting friction and improve risk management.✅ What's holding credit unions back from small business growth, and how to move it higher on the strategic priority list.✅ Why small business owners are among the most valuable long-term relationships a credit union can build.Subscribe to Credit Union Conversations for the latest credit union trends and insights on loan volume and business lending! Connect with MBFS to boost your credit union's growth today.TIMESTAMPS: 00:00 Welcome to Credit Union Conversations: Gord Baizley's career journey: law, finance, and tech03:05 What Judi.ai does and why small businesses are underserved04:03 Predictive AI vs. generative AI in lending06:00 Banking in Canada vs. the U.S.08:43 Why credit unions focus on CRE instead of small business09:22 Rethinking risk: small business vs. consumer credit10:15 Automation, open banking, and real-time cash flow data13:32 Regulatory shifts supporting cash flow lending14:33 Ideal credit unions for small business growth16:45 Treating small business as its own segment17:27 Why small business owners are “relationship unicorns”19:10 The biggest barriers to getting started21:00 Executive buy-in and strategic ownership23:00 The future outlook for credit unions25:12 How to connect with Gord and Judi.aiKEY TAKEAWAYS: Small business lending is a relationship growth engine, not just a loan product.Credit unions often apply the wrong risk lens to small business lending.Technology has removed the...

What's new when it comes to artificial intelligence (AI) and coding?Listen to the next edition of the long-running and popular Talk Ten Tuesday and learn from longtime RACmonitor and ICD10monitor contributing author Sharon Easterling.Sharon Easterling will continue her editorial series on artificial intelligence and medical record coding. The potential for AI in health information is both exciting and daunting as you'll learn.The popular Internet broadcast will also feature these additional instantly recognizable panelists, who will report more news during their segments:POV: Penny Jefferson, Manager of Coding & Clinical Documentation Integrity Services for the University of Davis Medical Center, is the new cohost of Talk Ten Tuesday. She will share her point of view (POV) during the broadcast.CDI Report: James S. Kennedy, president of CDIMD, will substitute for Cheryl Ericson and will provide an update on clinical documentation integrity (CDI).The Coding Report: Christine Geiger, Assistant Vice President of Acute and Post-Acute Coding Services for First Class Solutions, will report on the latest coding news.News Desk: Timothy Powell, ICD10monitor national correspondent, will anchor the Talk Ten Tuesdays News Desk.

In this episode of The Consultant's Counsel podcast, Kelsey Creveling speaks with Adam Qureshi and Istvan Hoka, co-founders of Fly Swift Tail, about their entrepreneurial journey in the private aviation industry. They discuss the challenges of building a startup, the importance of understanding market needs, and the impact of AI on business operations. The conversation also touches on regulatory hurdles, the founders' backgrounds, and practical advice for aspiring entrepreneurs.TakeawaysNetworking on LinkedIn can lead to unexpected partnerships.Understanding the problem is crucial for startup success.The private aviation market is fragmented and needs innovation.Regulatory challenges are significant in the aviation industry.Delineating responsibilities in a startup is essential for efficiency.Founders' diverse backgrounds contribute to their startup's vision.AI can enhance productivity and efficiency in business.Ethical considerations around AI are increasingly important.Entrepreneurs should embrace AI tools to stay competitive.Starting a side hustle can mitigate job risks.Chapters00:00 The Genesis of a Partnership02:21 Identifying Market Gaps in Private Aviation05:05 Navigating Regulatory Challenges07:35 Delineating Roles in a Startup10:03 The Journey to Product Market Fit12:52 Foundational Experiences of the Founders15:42 Building a Marketplace in the Tesla Space17:27 Istvan's Path to Entrepreneurship22:17 The Freedom of Entrepreneurship23:20 Building a Social Media Firewall25:23 The Impact of AI on Efficiency27:35 The Future of AI and Energy30:05 Addressing AI Fears and Ethical Considerations35:07 AI's Agency and Its Implications38:27 Preparing for the AI Revolution45:34 Advice for Future InnovatorsConnect with the Guests:Adam Qureshi on LinkedIn: https://www.linkedin.com/in/adamqureshi/Istvan Hoka on LinkedIn: https://www.linkedin.com/in/ihoka/Fly Swift Tail: https://flyswifttail.comConnect with Kelsey on LinkedIn: https://www.linkedin.com/in/kelseycrevelingWork with Kelsey: https://kelsc.consultingThanks to TORY for sponsoring this episode (Host Kelsey Creveling is the Founder & CEO of TORY). To learn more: https://inventory.capitalResources + Courses for Consultants: https://theconsultantscounsel.comFollow:The Consultant's Counsel Instagram - https://www.instagram.com/theconsultantscounselLinkedIn - https://www.linkedin.com/showcase/theconsultantscounselYouTube - https://www.youtube.com/@theconsultantscounselPartnerships & Affiliations:*Disclaimer: A brand affiliate relationship is in place with the following brands, and a commission may be earned if a purchase is made using the link or provided discount code.The Healing Mind™ - Download the app: https://apps.apple.com/app/apple-store/id1632086744?pt=125216772&ct=Kelsey%20Creveling&mt=8Riverside - Sign up today! https://www.riverside.fm/?utm_campaign=campaign_5&utm_medium=affiliate&utm_source=rewardful&via=kelscAlaska Rhodiola: A supplement that can fortify your stress response and help you handle life's difficulties with far more ease. Your workouts can be more frequent and intense, avoid needing a daily nap, and achieve an emotional state that is far more balanced.Use code KELSEY24 at checkout when you have two in your cart for Buy One Get One Free. https://www.akroseroot.com/?sca_ref=7400745.eAH0u5h9JI

The CLARITY Act Is Short-Sighted As Written #Crypto #Cryptocurrency #podcast #BasicCryptonomics #BlockDAG #Gold #Silver #Platinum #Palladium Website: ⁠⁠⁠⁠https://CryptoTalk.FM Facebook: ⁠⁠⁠⁠@ThisIsCTR⁠⁠⁠⁠ Discord:⁠⁠⁠⁠ @CryptoTalkRadio⁠⁠⁠⁠ Chapters (00:00:01) - Crypto Talk Radio(00:03:30) - The Clarity Act for Stable Coins(00:08:50) - The Clarity Act: Digital Commodities and Stable Coins(00:15:21) - Separation of Investment Contracts in Crypto(00:19:15) - What is a Permitted Payment Stablecoin?(00:27:30) - Will Cryptocurrency Companies Lock Down?(00:27:55) - CFTC and SEC: Exclusion of Defi Activities from Regulatory(00:33:34) - What is WASH Trading?(00:41:01) - Cryptocurrency: Should It Be Regulated?

Today's guest is Debjit Saha, VP of Engineering & Product for Risk & Compliance at MoneyGram. Debjit focuses on building data- and AI-driven controls for fraud, compliance, and payments decisioning. Debjit joins Emerj Editorial Director Matthew DeMello to explore how payments teams can modernize risk and compliance as fraud grows more sophisticated, customer tolerance for friction shrinks, and regulators demand stronger explainability. Debjit also highlights pragmatic steps leaders can take to build credibility quickly—starting with high-impact use cases, designing for auditability, and placing human oversight where it matters most. Want to share your AI adoption story with executive peers? Click emerj.com/e2 for more information and to be a potential future guest on Emerj's flagship 'AI in Business' podcast! If you're interested in unlocking our AI best practice guides, frameworks for AI ROI, and specific resources for AI consultants, visit emerj.com/p1.

Send us a textCarli Kistler-Miller, Emily Riley and David Wynn discuss key regulations and proposed rules from Washington D.C. in 2025 that affect our precision machining shops. For More Information Visit pmpa.org/podcasts

In this episode, Etienne Nichols and guest Ashkon Rasooli explore the transformative impact of AI in the medical device industry. From AI-driven diagnostics and wearable health monitors to the future of surgical robots, they delve into how these technologies are reshaping healthcare. The discussion also touches on the challenges and opportunities in validating and regulating AI within MedTech, highlighting real-world applications and predicting future trends."Validation of AI tools in MedTech requires a staged adoption to build confidence due to the inherent uncertainty in AI outcomes." - Ashkon Rasooli00:00 - Introduction to AI in MedTech05:15 - Discussing AI's deterministic vs. statistical nature12:30 - AI in diagnostics: Radiology, Cardiology, and Neurology20:45 - Wearable health monitors and patient-driven health data28:10 - The role of AI in medical device operations and manufacturing35:00 - AI at the point of care: Enhancing patient and clinician experience42:15 - Regulatory challenges and the future of AI in healthcareKey Takeaways:1. Latest MedTech Trends:The integration of AI in diagnostics is growing, particularly in radiology, cardiology, and neurology, aiding in more accurate and quicker diagnoses.Wearable health monitors are empowering patients to take control of their health data, leading to personalized healthcare solutions.2. Practical Tips for MedTech Enthusiasts:Stay informed about the latest AI advancements and regulatory guidelines to leverage AI effectively in MedTech.Consider the ethical implications and ensure bias mitigation in AI model training and deployment.3. Predictions for the Future:Increased adoption of AI across various healthcare sectors, including surgery and patient care management.Evolution of regulatory frameworks to better accommodate and oversee AI-driven medical devices.References:Ashkon Rasooli on LinkedInashkon@engeniussolutions.comEngenius SolutionsAFDO/RAPS Working GroupEtienne Nichols on LinkedInSponsors:This episode is brought to you by Greenlight Guru, a comprehensive solution designed to streamline MedTech product development and ensure regulatory compliance. Discover how Greenlight Guru can accelerate your projects at www.greenlight.guruShare your thoughts and questions with us at podcast@greenlight.guru

Axenya is rebuilding healthcare around chronic disease prevention through AI-powered continuous monitoring. Covering 100,000 lives in Brazil and processing 95 million clinical inferences monthly, the company pivoted from clinical technology provider to healthcare broker - achieving cash flow positive status before their Series A. In this episode of BUILDERS, I sat down with Mariano García-Valiño, CEO and Founder of Axenya, to learn how they spent $3 million building the "perfect product" before discovering no one would pay for it, why they acquired a small broker to unlock their revenue model, and their regulatory-constrained approach to geographic expansion. Topics Discussed: Axenya's shift from infectious disease to chronic disease management through wearables and AI The 12-month zero-revenue period after spending $3 million on product development Why doctors, patients, and health plans all failed as buyers despite clinical validation The broker acquisition that unlocked their business model Performance-based pricing: zero fees upfront, revenue from cost savings only Regulatory barriers determining expansion (Mexico viable, Argentina impossible, Europe requires model redesign) Field-force-driven GTM with 30+ salespeople for complex, high-ACV enterprise deals Path to cash flow positive before Series A and scaling playbook for 2026 // Sponsors: Front Lines — We help B2B tech companies launch, manage, and grow podcasts that drive demand, awareness, and thought leadership. www.FrontLines.io The Global Talent Co. — We help tech startups find, vet, hire, pay, and retain amazing marketing talent that costs 50-70% less than the US & Europe. www.GlobalTalent.co // Don't Miss: New Podcast Series — How I Hire Senior GTM leaders share the tactical hiring frameworks they use to build winning revenue teams. Hosted by Andy Mowat, who scaled 4 unicorns from $10M to $100M+ ARR and launched Whispered to help executives find their next role. Subscribe here: https://open.spotify.com/show/53yCHlPfLSMFimtv0riPyM

The Centers for Medicare & Medicaid Services (CMS) will block hospitals from performing certain interventions that are intended to change a child's physical appearance to align an asserted sex identity.Reporting the lead story during the next live edition of Monitor Mondays will be independent physician consultant Dr. Drew Updike.More than four weeks since its last news broadcast, Monitor Mondays will return this coming Monday, Jan. 12, with a cadre of the smartest minds in healthcare auditing. You'll hear auditing news you won't find anywhere else – except here the RACmonitor.Broadcast segments will also include these instantly recognizable features:Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.Legislative Update: Matthew Albright, chief legislative affairs liaison for Zelis, will report on current healthcare legislation.

Medical oncologist, geriatrician, and physician scientist GJ van Londen and Chief of Genetic and Genomic Medicine at the University of Pittsburgh School of Medicine Gerald Vockley discuss the article "FDA delays could end vital treatment for rare disease patients." GJ and Gerald explore the complex regulatory impasse where the U.S. Food and Drug Administration denied standard approval for elamipretide despite a positive advisory committee vote, creating a financial crisis that threatens to cut off supply for everyone. GJ shares his personal journey from treating cancer to living with primary mitochondrial myopathy, while the conversation emphasizes the critical need for the agency to use the flexibility granted by the Orphan Drug Act to save a treatment that has already proven its worth. Join us to understand the life-or-death stakes hidden behind administrative decisions. This episode is presented by Scholar Advising, a fee-only financial advising firm specializing in providing advice for DIY investors. If you want clear, actionable strategies and confidence that your financial decisions are built on objective advice without AUM fees or commissions, Scholar is designed for you. Physicians often navigate complex compensation structures, including W-2 income, 1099 work, production bonuses, and practice ownership. Scholar's highly credentialed advisors guide high-earners through decisions like optimizing investments for long-term tax efficiency and expert strategies for financial independence. Every recommendation is tailored to the financial realities physicians face. VISIT SPONSOR → https://scholaradvising.com/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Arrash Yasavoli discusses how you should jump on investing in bitoin in 2026! Arrash's path from data engineering at LinkedIn into quantitative trading, crypto, and building Glitch, a SaaS platform that gives broader access to advanced trading strategies gives a unique perspective into possible 2026 investing plans. We also talk Bitcoin's role as a potential store of value, the divergence between Bitcoin and altcoins, the growing importance of real utility and valuation in crypto projects, the rise of ETFs and stablecoins as bridges to mainstream adoption, and more. We discuss... Crypto's transition from a speculative and "scammy" perception toward broader legitimacy through regulation, ETFs, and institutional adoption. Bitcoin is increasingly viewed as a store of value similar to gold rather than a scalable transactional currency. Bitcoin's fixed supply and resilience through multiple market cycles were highlighted as key drivers of long-term investor confidence. Bitcoin's historical growth rates are unlikely to persist, with future returns likely slowing and volatility remaining high. The growing divergence between Bitcoin performance and stagnant altcoins was identified as a sign of increasing market maturity. Many altcoins from earlier cycles failed due to hype-driven models that never delivered real value. The current crypto cycle was compared to the post–dot-com bust era, where focus shifts from excitement to sustainable business models. Regulatory clarity, including frameworks for crypto and stablecoins, was viewed as a major catalyst for continued adoption. Whether investors should trade or hold crypto, with emphasis on patience and fundamentals over speculation. Future crypto valuation models were described as moving toward revenue, profitability, and clear value propositions. Arrash outlined his work on BitTensor, a blockchain designed to create and trade real digital commodities. Crypto's long-term value lies in practical applications that quietly use blockchain under the hood rather than hype-driven narratives. Today's Panelists: Kirk Chisholm | Innovative Wealth Barbara Friedberg | Barbara Friedberg Personal Finance Follow on Facebook: https://www.facebook.com/moneytreepodcast Follow LinkedIn: https://www.linkedin.com/showcase/money-tree-investing-podcast Follow on Twitter/X: https://x.com/MTIPodcast For more information, visit the show notes at https://moneytreepodcast.com/investing-in-bitcoin-in-2026-arrash-yasavolian-780 

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Simone Colgan Dunlap, National Vice Chair of the Quarles Health and Life Sciences Practice Group, and Amy Cotton Peterson, Partner at Quarles. As more automation solutions become available, its vital specialty pharmacy providers strategically approach acquisition of targets that offer technology and AI assets. This discussion explores effective diligence practices, common pitfalls, and risk mitigation strategies for specialty pharmacies navigating mergers and acquisitions and the rapidly evolving use of artificial intelligence.  

New @greenpillnet pod out today!

PREVIEW FOR LATER TODAY REGULATORY HURDLES AND HIGH WINDS FUEL PALISADES FIREColleague Jeff Bliss, Pacific Watch. Jeff Bliss reports on the January 2025 Pacific Palisades fire, allegedly ignited by an arsonist and exacerbated by Santa Ana winds. Bliss notes that state regulations protecting a specific plant prevented fire crews from bulldozing underbrush, allowing embers to reignite and causing the catastrophe to rapidly expand.1919 PACIFIC PALISADES

In this episode of The Daily, we uncover why many freight brokers are structurally losing roughly $19 on every load despite seemingly stable contract rates. We break down the "negative operating leverage trap" detailed in How are Freight Brokers Staying Afloat? that is forcing companies to burn cash while desperately chasing volume. The conversation shifts to the rail sector, where CSX lays off 5% of management staff, furloughs conductors in a move that signals a permanent shift toward leaner operations. These deep cuts reflect a broader industry trend of redrawing profitable baselines amidst challenging economic conditions and declining high-margin traffic. Regulatory pressure is also intensifying, as the DOT strips California of $160M over foreign truckers for failing to revoke thousands of unlawfully issued commercial driver's licenses. This systemic collapse in the state's licensing process threatens to tighten capacity further in the stressed West Coast freight market. We also examine compliance risks, highlighting a case where an air cargo contractor reimburses Postal Service for fraudulent billing after falsifying delivery scans to avoid late penalties. This recurring pattern of fraud underscores the rigorous compliance demands fleets must manage alongside financial pressures. Physical risks are escalating as well, with new analysis on Minneapolis, 1992, and What Fleets Need to Know About the Insurrection Act as state and federal tensions create volatile conditions for urban logistics. Fleet operators are urged to prioritize real-time visibility and safety training to navigate these potential disruptions effectively. Finally, we look at market data where U.S. Bank, DAT launch quarterly truck freight rates report showing that carrier capacity is quietly shrinking while contract rates hold steady. This disconnect raises the critical question of which sector will force a necessary margin reset in the coming year. Follow the FreightWaves NOW Podcast Other FreightWaves Shows Learn more about your ad choices. Visit megaphone.fm/adchoices

As Maryland heads toward another consequential legislative session, energy policy is once again front and center, and counties are feeling the pressure.In this episode of the Conduit Street Podcast, hosts Kevin Kinnally and Dominic Butchko are joined by Valencia McClure, Senior Vice President of Governmental, Regulatory, and External Affairs at Exelon, for a wide-ranging conversation on energy security, rising costs, and grid reliability.The discussion explores why Maryland is facing growing risks, including surging demand driven by data centers and electrification, limited in-state generation capacity, and an aging grid. McClure explains what it means for Maryland to be a net importer of electricity, why supply costs are driving up residents' bills, and how projected shortfalls could lead to brownouts as early as 2027 if action is delayed.The episode also dives into the evolving policy debate over who should build new generation, the role utilities could play alongside merchant generators, and why counties, though not energy regulators, are often on the front lines when reliability falters or costs spike.For county leaders, policymakers, and anyone trying to understand what's behind today's energy headlines, this conversation offers timely context on the challenges ahead and the decisions that will shape Maryland's energy future.Learn More:Maryland Power Supply Crisis | Take Back Our Power MDFollow us on Socials!MACo on TwitterMACo on Facebook

As global supply chains navigate through cybersecurity threats and rapid technological integration, companies must rethink their strategies to stay competitive. Cybercriminals are increasingly targeting corporate systems through sophisticated tactics, such as email infiltration, to gain access to sensitive data, including bills of lading. This underscores the need for organizations to strengthen their cybersecurity and ensure their supply chains remain secure.In this episode of Supply Chain Now, Scott Luton and Karin Bursa sit down with Gustav Khambatta, SVP, Head of Freight Payment Sales at U.S. Bank, to explore key themes in supply chain management. They discuss the evolving role of cybersecurity, AI's impact on the industry, and the challenges posed by cargo theft and security breaches.They talk about the intersection of AI and cybersecurity, highlighting how technology is transforming business operations. AI is being integrated into supply chain processes, with use cases ranging from fraud prevention to streamlining document verification. However, as AI adoption accelerates, so does the potential for security vulnerabilities. The conversation underscores the importance of continuous adaptation in a rapidly changing supply chain landscape, where technology and security will play a central role in shaping the future.Jump into the conversation:(00:00) Intro(04:02) Sports talk: Patriots, Falcons, F1(06:19) Gustav's professional journey(08:01) US Bank Freight Payment Index insights(14:39) Cybersecurity in the corporate world(20:22) AI in supply chain and cybersecurity(23:28) AI and cybersecurity integration(24:08) Regulatory environment and leadership challenges(24:38) Supply chain evolution and technology(27:26) AI in supply chain management(29:35) Reflections on 2025(32:29) Energy demand and AI(37:02) Predictions for 2026Additional Links & Resources:Connect with Gustav Khambatta: https://www.linkedin.com/in/gustav-khambatta-384852/Learn more about U.S. Bank: https://www.usbank.com/index.htmlDownload the most recent edition of the U.S. Bank Freight Payment Index: bit.ly/scn-us-bankLearn more about Supply Chain Now: https://supplychainnow.comWatch and listen to more Supply Chain Now episodes here: https://supplychainnow.com/program/supply-chain-nowSubscribe to Supply Chain Now on your favorite platform: https://supplychainnow.com/join

Get 2026 started of Right! Join us as we discuss what making a New Year's resolution really means and how to stay true to yourself and your intentions. For our Legislative and Regulatory update we're talking biosecurity, outbreaks, and where you should look for correct information. Happy New Year!HORSES IN THE MORNING Episode 3856 –Show Notes and Links:Your Hosts: Julie Broadway (President) and Emily Stearns (Health, Welfare, and Regulatory Affairs Liaison) of the American Horse CouncilGuest: Karen Chaton of the Endurance Rider PodcastGuest: Meghan Brady of the Galloping Getaways PodcastLink: USDA APHIS Equine DiseaseLink: Equine Disease Communication CenterLink: Find your state animal health official (via United States Animal Health Association)Sponsors: AHC Board of Trustees, AHC Committees and AHC Staff | AHC FoundationSubscribe to the American Horse Council Podcast - Search American Horse Council Podcast on your podcast player.Follow Horses In The Morning on FacebookFollow the American Horse Council on Facebook, Instagram and X (formerly Twitter)